BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9587185)

  • 21. Cell vacuolization induced by Helicobacter pylori VacA cytotoxin does not depend on late endosomal SNAREs.
    de Bernard M; Moschioni M; Habermann A; Griffiths G; Montecucco C
    Cell Microbiol; 2002 Jan; 4(1):11-8. PubMed ID: 11856169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vacuolating toxin production in clinical isolates of Helicobacter pylori with different vacA genotypes.
    Wang HJ; Kuo CH; Yeh AA; Chang PC; Wang WC
    J Infect Dis; 1998 Jul; 178(1):207-12. PubMed ID: 9652442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori vacuolating toxin accumulates within the endosomal-vacuolar compartment of cultured gastric cells and potentiates the vacuolating activity of ammonia.
    Ricci V; Sommi P; Fiocca R; Romano M; Solcia E; Ventura U
    J Pathol; 1997 Dec; 183(4):453-9. PubMed ID: 9496263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein.
    Schmitt W; Haas R
    Mol Microbiol; 1994 Apr; 12(2):307-19. PubMed ID: 8057855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori cytotoxin induces vacuolation of primary human mucosal epithelial cells.
    Harris PR; Cover TL; Crowe DR; Orenstein JM; Graham MF; Blaser MJ; Smith PD
    Infect Immun; 1996 Nov; 64(11):4867-71. PubMed ID: 8890255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleiotropic actions of Helicobacter pylori vacuolating cytotoxin, VacA.
    Isomoto H; Moss J; Hirayama T
    Tohoku J Exp Med; 2010 Jan; 220(1):3-14. PubMed ID: 20046046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In search of the Helicobacter pylori VacA mechanism of action.
    Papini E; Zoratti M; Cover TL
    Toxicon; 2001 Nov; 39(11):1757-67. PubMed ID: 11595638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping of a domain required for protein-protein interactions and inhibitory activity of a Helicobacter pylori dominant-negative VacA mutant protein.
    Torres VJ; McClain MS; Cover TL
    Infect Immun; 2006 Apr; 74(4):2093-101. PubMed ID: 16552038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of vacuolating toxin of Helicobacter pylori in human faeces.
    Luzzi I; Pezzella C; Caprioli A; Covacci A; Bugnoli M; Censini S
    Lancet; 1993 May; 341(8856):1348. PubMed ID: 8098476
    [No Abstract]   [Full Text] [Related]  

  • 30. Outer membrane targeting of passenger proteins by the vacuolating cytotoxin autotransporter of Helicobacter pylori.
    Fischer W; Buhrdorf R; Gerland E; Haas R
    Infect Immun; 2001 Nov; 69(11):6769-75. PubMed ID: 11598049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of monoclonal antibodies neutralizing vacuolation of cultured cells by Helicobacter pylori cytotoxin.
    Yamaguchi H; Osaki T; Taguchi H; Kamiya S
    FEMS Microbiol Lett; 1998 Nov; 168(2):277-82. PubMed ID: 9835039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Overview of Helicobacter pylori VacA Toxin Biology.
    Foegeding NJ; Caston RR; McClain MS; Ohi MD; Cover TL
    Toxins (Basel); 2016 Jun; 8(6):. PubMed ID: 27271669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RACK1 protein interacts with Helicobacter pylori VacA cytotoxin: the yeast two-hybrid approach.
    Hennig EE; Butruk E; Ostrowski J
    Biochem Biophys Res Commun; 2001 Nov; 289(1):103-10. PubMed ID: 11708784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vacuolating cytotoxin production by Helicobacter pylori isolates from peptic ulcer, atrophic gastritis and gastric carcinoma patients.
    Murakita H; Hirai M; Ito S; Azuma T; Kato T; Kohli Y
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S29-31. PubMed ID: 7735931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from China.
    Pan ZJ; Berg DE; van der Hulst RW; Su WW; Raudonikiene A; Xiao SD; Dankert J; Tytgat GN; van der Ende A
    J Infect Dis; 1998 Jul; 178(1):220-6. PubMed ID: 9652444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol.
    de Bernard M; Burroni D; Papini E; Rappuoli R; Telford J; Montecucco C
    Infect Immun; 1998 Dec; 66(12):6014-6. PubMed ID: 9826387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vacuolating cytotoxic activity of 40 Helicobacter pylori strains isolated from Turkish patients.
    Ozsan M; Tekeli A; Ozden A; Akyön Y; Ozkul A; Gerçeker D; Cetinkaya H
    APMIS; 2000 Apr; 108(4):293-5. PubMed ID: 10843418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The vacuolating cytotoxin of Helicobacter pylori.
    Cover TL
    Mol Microbiol; 1996 Apr; 20(2):241-6. PubMed ID: 8733223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosol.
    de Bernard M; Arico B; Papini E; Rizzuto R; Grandi G; Rappuoli R; Montecucco C
    Mol Microbiol; 1997 Nov; 26(4):665-74. PubMed ID: 9427397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of glutathione metabolism in human gastric epithelial cells treated with vacuolating cytotoxin from Helicobacter pylori.
    Kimura M; Goto S; Ihara Y; Wada A; Yahiro K; Niidome T; Aoyagi H; Hirayama T; Kondo T
    Microb Pathog; 2001 Jul; 31(1):29-36. PubMed ID: 11427034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.